eduardo epstein

Participation in the due diligence and acquisiction of a family owned pharma company by Advent International (a leading company in Onco-Hematology and HIV products in Argentina). Reeingineering, business definition and portfolio management. Pipeline reengineering process. Twelve Onco-Hematology products launched in one year. The Pharma Business Unit growth was 50% per year (2 years) and Onco-Special business Unit was 44% and 27 % growth in two years. Master plan for all production plants in order to pass against regional agencies. Mercosur accreditation.

Reengineering and professionalization of family owned business after acquisition by Advent International. Portfolio management. Strategic repositioning. Manufacturing facilities upgrade.

Reassembly of portfolio and repositioning of a company leader in generic injectables

Acquisition of leading oncology business in Argentina (lab Rontag). Reengineering trade policies. Merge of Searle and Pharmacia Upjohn oncology business.

Adapting global marketing strategies in Latin America. Estartegias of pharmacoeconomics. Support for the launch of Celebrex

Programa Ejecutivo de la Escuela de Negocios de la Universidad Torcuato Di Tella

Merge and acquisiton of Galeno, Life and TIM (HMOs located in Buenos Aires). First Managed Care Program implementation in Argentina (otuside of a comunity hospital). Disease management programs, medical profiling, new reimbursement models for physicians. ICD9 diagnostic code imlementation for inpatient management.

Development of the first plan of Managed Care in Argentina. Residency training program development and support. Teaching and clinical research. Intensive involvement in the development of the Health Plan of the Italian Hospital. Clinical epidemiology and statistcs training.